Topics
Gliomas | Treatment | Targeted therapy | BRAF/MEK inhibitors
Home > Publications > Topics > Gliomas > Treatment > Targeted therapy > BRAF/MEK inhibitors
Khoury
JE, Wehbe S, Attieh F, Boutros M, Kesrouani C, Kourie HR.
A
critical review of RAF inhibitors in BRAF-mutated glioma
treatment.
Pharmacogenomics.
2024 Jun 3:1-13. doi:
10.1080/14622416.2024.2355859. PMID:
38884947. Review˰
ˍ
Bazer DA, Kolchinski A, Bush NAO, Clarke JL, Bagley SJ, Schreck
KC.
No drug
holidays in BRAFV600E
glioma patients: An argument for dose reduction
of targeted therapies.
Neurooncol
Pract. 2024 May 24;11(5):660-664. doi:
10.1093/nop/npae046. PMID:
39279775. Case report˰
ˍ